Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Monday. The brokerage issued a hold rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Trading Down 8.5 %

MLSS opened at $1.08 on Monday. The firm has a market cap of $84.12 million, a price-to-earnings ratio of -15.43 and a beta of 1.10. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.27. The stock has a fifty day moving average price of $0.87 and a 200-day moving average price of $0.89.

Insider Activity

In related news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

Hedge funds have recently modified their holdings of the company. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific in the third quarter valued at approximately $48,000. Geode Capital Management LLC grew its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares in the last quarter. Finally, World Investment Advisors LLC acquired a new stake in Milestone Scientific in the third quarter valued at approximately $91,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.